FDAFDA · Food and drugs·Recall number D-0898-2017
Levophed norepinephrine bitartrate, injection, USP, 4 mg /4 mL (1 mg/mL),Rx only, Hospira, Inc. Lake Forest, IL --- NDC 0409-3375-04
Published June 21, 2017 · Recall initiated: May 18, 2017
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
GMP Deviation; A foreign stopper was observed during packaging of a lot of product.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- LEVOPHED
- Manufacturer
- Hospira Inc., A Pfizer Company
- Distributor
- Nationwide, Canada and Singapore
- Lot
- 720503A, 720603A (Canada only)
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.